34 results
424B4
NRBO
NeuroBo Pharmaceuticals Inc
7 Nov 22
Prospectus supplement with pricing info
9:07am
reputation may suffer.
We believe that any of these events could prevent us from achieving or maintaining market acceptance of the affected product … demand for any product candidate that we are developing;
injury to our reputation and significant negative media attention;
withdrawal of clinical
8-K
EX-10.3
sjx0ekyrhvstw10
4 Nov 21
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President
8:10am
8-K
EX-10.1
wpqavjt
13 Feb 20
Departure of Directors or Certain Officers
4:01pm
8-K
EX-10.1
w0p1v5w25de
30 Dec 19
Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals
9:04pm
8-K
EX-10.3
yu4hh
30 Dec 19
Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals
9:04pm
424B3
vvlbk8diwgr9z6 b1
6 Nov 19
Prospectus supplement
9:15am
S-4/A
my2ox
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4
o1v2 jwbp
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.37
1m9w 74qpu82q7
3 Sep 19
Registration of securities issued in business combination transactions
12:00am